RBC Life Sciences, Inc.
RBCL
$0.0001
$0.000.00%
| 09/30/2015 | 06/30/2015 | 03/31/2015 | 12/31/2014 | 09/30/2014 | |
|---|---|---|---|---|---|
| Net Income | 234.65% | 55.35% | -481.40% | 23.46% | -1,772.73% |
| Total Depreciation and Amortization | -13.05% | 32.33% | -12.28% | -20.01% | 6.70% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -1,733.91% | 67.50% | -1,100.97% | -162.35% | 591.67% |
| Change in Net Operating Assets | -950.83% | 214.64% | -126.36% | 234.25% | -219.22% |
| Cash from Operations | -10,451.13% | 103.08% | -225.63% | 259.26% | -175.70% |
| Capital Expenditure | -- | 100.00% | 81.55% | 13.05% | 29.50% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 200.00% | -- |
| Cash from Investing | -- | 100.00% | 76.97% | 40.60% | 17.32% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1,702.64% | -2.16% | -1.65% | -2.05% | -1.90% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -1,702.64% | -2.16% | -1.65% | -2.05% | -1.90% |
| Foreign Exchange rate Adjustments | 1,085.90% | 154.55% | -179.74% | 19.03% | 1,908.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 17,149.28% | 99.31% | -291.11% | 173.17% | -491.67% |
